Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruoheng Wei

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|November 14, 2025
From reactive to predictive: Advancing biologic dosing in dermatologyAnke Eylenbosch, Ruoheng Wei, Rani Soenen, et al.
British Journal of Clinical Pharmacology|February 15, 2026
Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world dataCharlotte M Thomas, Jessica Ruoheng Wei, David Baudry, et al.
BMJ Open|October 10, 2025
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasisWeiyu Ye, Kingsley Powell, Niamh Dooley, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the European Academy of Dermatology and Venereology : JEADV|November 14, 2025
From reactive to predictive: Advancing biologic dosing in dermatologyAnke Eylenbosch, Ruoheng Wei, Rani Soenen, et al.
British Journal of Clinical Pharmacology|February 15, 2026
Pharmacokinetic-pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real-world dataCharlotte M Thomas, Jessica Ruoheng Wei, David Baudry, et al.
BMJ Open|October 10, 2025
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasisWeiyu Ye, Kingsley Powell, Niamh Dooley, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
Pageof 1